Menu Back toSESSION-9-EMA-REGULATIONS-AND-POLICIES-BETTER-FOR-PATIENTS

Clinical Trial Regulation Conference

This conference provides a forum for information exchange and discussion on conceptual and practical questions about critical issues affecting sponsors and Member States regarding the implemention the regulation.


SESSION 9: EMA Policy 0070: Challenges and Techniques for Sponsors

Session Chair(s)

Merete  Joergensen, MBA, MSc

Merete Joergensen, MBA, MSc

  • Senior Trial Disclosure Director, Clinical Transparency
  • Novo Nordisk A/S, Denmark

Speaker(s)

Nicole  Hinton

Industry Experience with Preparing Documents for Submission

Nicole Hinton

  • Associate Director, Clinical Trial Transparency
  • Ultragenyx, United States
Mats  Ericson, PhD

Mats Ericson, PhD

  • Director Regulatory Affairs
  • Amgen, France
Janice  Branson, MSc

Technical Solutions to Ease the Process of Redaction/ Anonymisation/Justification

Janice Branson, MSc

  • VP Head of Statistics, Immunology & Dermatology Unit
  • Novartis Pharma AG, Switzerland

Contact us

 Registration Questions

Send Email
+41 61 225 51 51


Agenda and Logistics Questions

Send Email
+41 61 225 51 49